癌における酸化ストレス:腫瘍と微小環境の改造から治療の境界まで

Xisong Liang^1,2,3, Jiadi Weng^1,2,3,4, Zhongyi You^1,2,3,4

¹Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, 410008, P. R. China.

Molecular cancer

|August 23, 2025

まとめ

酸化ストレス反応性酸素種 (ROS) の不均衡が癌の鍵ですこのネットワークをターゲットにすることで新しい治療戦略が生まれます特に免疫療法とナノ医療を組み合わせることでより良いがん治療が可能になります

科学分野:

腫瘍学
細胞生物学
ガン治療薬

背景:

酸化ストレスは,高濃度の活性酸素種 (ROS) から生じる酸化還元シグナルの不調とマクロ分子損傷によって特徴づけられ,がんの重要な特徴である.
腫瘍細胞の成長と腫瘍の微小環境に大きな影響を及ぼし癌治療の開発の重要な標的となっています
酸化ストレスを標的とする課題は,異なる癌の複雑な異質な規制から生じます.

研究の目的:

腫瘍細胞内の酸化ストレスネットワークとがんにおけるその役割を理解する
癌における酸化ストレスを標的とした現在の治療戦略をレビューする.
新興の臨床応用と酸化ストレスベースのアプローチの可能性を強調し,特に組み合わせ治療において.

主な方法:

癌における酸化ストレス発生と制御に関する既存の文献のレビュー.
腫瘍細胞と腫瘍の微小環境における酸化ストレスの役割の分析
免疫療法とナノ医療との組み合わせを含む,現在および新興の治療戦略の要約.

主要な成果:

酸化ストレスネットワークは腫瘍細胞と微小環境に影響を及ぼし癌の生物学の不可欠な要素です
酸化ストレスを標的とする現在の治療戦略は有望ですが,がんの異質性のために課題に直面しています.
酸化ストレス標的療法と免疫療法とナノ医薬品の組み合わせは,相乗効果の利点を提供します.

結論:

酸化ストレスはがん治療の重要な標的であり,がんの生物学にも重大な影響を及ぼします.
抗酸化ストレスを標的とするアプローチを免疫療法とナノ医療と統合することで癌の治療を向上させる有望な方法が生まれます
将来の研究は,治療に対する耐性を克服し,がんを排除するための組み合わせた治療のプラットフォームを開発することに焦点を当てるべきです.

キーワード:

抗酸化物質免疫細胞免疫療法ナノ医療 ROS について

さらに関連する動画

09:31

Analyzing Oxidative Stress in Murine Intestinal Organoids using Reactive Oxygen Species-Sensitive Fluorogenic Probe

Published on: September 17, 2021

4.2K

10:23

Author Spotlight: Computing the Effects of a Local Radiofrequency Hyperthermia Intervention on Tumor Biomechanics

Published on: December 1, 2023

539

関連する概念動画

02:17

The Tumor Microenvironment

6.8K

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

6.8K

02:49

Cancer Therapies

7.9K

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

7.9K

02:53

Adaptive Mechanisms in Cancer Cells

5.9K

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

5.9K

01:46

Electron Transport Chain: Complex I and II

15.0K

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...

15.0K

02:57

Targeted Cancer Therapies

7.8K

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

7.8K

02:56

Treatment Resistant Cancers

3.4K

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...